Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
JNJ Johnson & Johnson	$151.82 +0.3%	$154.01	$140.68 ▼ $169.99	$365.27B	0.42	9.13 million shs	687,043 shs
KVUE Kenvue	$21.31 -0.3%	$22.99	$17.67 ▼ $25.17	$40.88B	0.98	16.19 million shs	934,737 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
JNJ Johnson & Johnson	+1.02%	-2.52%	-1.17%	-6.09%	+1.73%
KVUE Kenvue	+0.02%	-1.18%	-9.97%	-7.32%	+15.43%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
JNJ Johnson & Johnson	4.9334 of 5 stars	3.3	5.0	4.2	3.9	3.0	1.7	1.9
KVUE Kenvue	3.4559 of 5 stars	2.2	5.0	2.5	0.0	3.6	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
JNJ Johnson & Johnson	2.55	Moderate Buy	$170.88	12.56% Upside
KVUE Kenvue	2.42	Hold	$25.33	18.91% Upside

Current Analyst Ratings Breakdown

Latest KVUE and JNJ Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/13/2025	KVUE Kenvue	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
6/5/2025	JNJ Johnson & Johnson	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$181.00
5/13/2025	JNJ Johnson & Johnson	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
5/13/2025	JNJ Johnson & Johnson	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform	$169.00 ➝ $153.00
5/12/2025	KVUE Kenvue	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$22.00 ➝ $23.00
5/9/2025	KVUE Kenvue	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$24.00 ➝ $25.00
5/9/2025	KVUE Kenvue	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$22.00 ➝ $24.50
4/24/2025	JNJ Johnson & Johnson	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
4/17/2025	JNJ Johnson & Johnson	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$166.00 ➝ $165.00
4/16/2025	JNJ Johnson & Johnson	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
4/16/2025	JNJ Johnson & Johnson	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$181.00 ➝ $181.00

(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
JNJ Johnson & Johnson	$88.82B	4.11	$13.29 per share	11.42	$29.69 per share	5.11
KVUE Kenvue	$15.46B	2.64	$1.47 per share	14.54	$5.04 per share	4.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
JNJ Johnson & Johnson	$14.07B	$8.99	16.89	13.71	2.27	24.42%	33.46%	13.30%	7/16/2025 (Estimated)
KVUE Kenvue	$1.03B	$0.55	38.74	17.18	3.32	6.90%	20.87%	8.04%	8/5/2025 (Estimated)

Latest KVUE and JNJ Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/16/2025	Q2 2025	JNJ Johnson & Johnson	$2.65	N/A	N/A	N/A	$22.85 billion	N/A
5/8/2025	Q1 2025	KVUE Kenvue	$0.23	$0.24	+$0.01	$0.17	$3.69 billion	$3.74 billion
4/15/2025	Q1 2025	JNJ Johnson & Johnson	$2.59	$2.77	+$0.18	$4.54	$21.65 billion	$21.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
JNJ Johnson & Johnson	$5.20	3.43%	N/A	57.84%	64 Years
KVUE Kenvue	$0.82	3.85%	N/A	149.09%	1 Years

Latest KVUE and JNJ Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/15/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.37%	5/27/2025	5/27/2025	6/10/2025
4/16/2025	KVUE Kenvue	quarterly	$0.2050	3.57%	5/14/2025	5/14/2025	5/28/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
JNJ Johnson & Johnson	0.49	1.26	1.03
KVUE Kenvue	0.63	0.86	0.60

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
JNJ Johnson & Johnson	69.55%
KVUE Kenvue	97.64%

Insider Ownership

Company	Insider Ownership
JNJ Johnson & Johnson	0.16%
KVUE Kenvue	0.17%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
JNJ Johnson & Johnson	138,100	2.41 billion	2.40 billion	Optionable
KVUE Kenvue	22,000	1.92 billion	1.92 billion	Optionable

KVUE and JNJ Headlines

Recent News About These Companies

LaFleur & Godfrey LLC Purchases 52,414 Shares of Kenvue Inc. (NYSE:KVUE)

June 24 at 6:21 AM | marketbeat.com

Cooper Investors PTY Ltd. Grows Stock Position in Kenvue Inc. (NYSE:KVUE)

June 24 at 5:46 AM | marketbeat.com

KVUE- A Beauty Care Turnaround Play Mulling Key Moves

June 24 at 12:36 AM | finance.yahoo.com

When Should You Buy Kenvue Inc. (NYSE:KVUE)?

June 23 at 9:33 AM | finance.yahoo.com

TrueMark Investments LLC Has $5.06 Million Position in Kenvue Inc. (NYSE:KVUE)

June 23 at 5:51 AM | marketbeat.com

Kentucky Retirement Systems Insurance Trust Fund Invests $1.34 Million in Kenvue Inc. (NYSE:KVUE)

June 23 at 5:06 AM | marketbeat.com

Manning & Napier Advisors LLC Has $6.40 Million Stake in Kenvue Inc. (NYSE:KVUE)

June 23 at 5:05 AM | marketbeat.com

Wealth Enhancement Advisory Services LLC Raises Stock Position in Kenvue Inc. (NYSE:KVUE)

June 23 at 3:21 AM | marketbeat.com

Coho Partners Ltd. Sells 128,091 Shares of Kenvue Inc. (NYSE:KVUE)

June 22 at 6:37 AM | marketbeat.com

Kingswood Wealth Advisors LLC Acquires Shares of 17,238 Kenvue Inc. (NYSE:KVUE)

June 22 at 3:50 AM | marketbeat.com

Envestnet Portfolio Solutions Inc. Cuts Holdings in Kenvue Inc. (NYSE:KVUE)

June 21 at 4:23 AM | marketbeat.com

Kenvue Inc. (NYSE:KVUE) Receives $25.33 Consensus Target Price from Brokerages

June 21 at 1:35 AM | americanbankingnews.com

Kenvue Inc. (NYSE:KVUE) Shares Sold by Norris Perne & French LLP MI

June 19, 2025 | marketbeat.com

Kenvue Inc. (NYSE:KVUE) Shares Bought by ORG Wealth Partners LLC

June 19, 2025 | marketbeat.com

Kenvue Inc. (NYSE:KVUE) Shares Bought by Global X Japan Co. Ltd.

June 19, 2025 | marketbeat.com

Exchange Traded Concepts LLC Acquires 36,480 Shares of Kenvue Inc. (NYSE:KVUE)

June 19, 2025 | marketbeat.com

Kenvue: Potential For Guidance To Be Revised Downwards

June 18, 2025 | seekingalpha.com

Investors Purchase Large Volume of Call Options on Kenvue (NYSE:KVUE)

June 18, 2025 | marketbeat.com

Kenvue Inc. (NYSE:KVUE) Position Trimmed by Community Bank N.A.

June 18, 2025 | marketbeat.com

Kenvue Inc. (NYSE:KVUE) Given Consensus Rating of "Hold" by Analysts

June 18, 2025 | marketbeat.com

Birch Hill Investment Advisors LLC Has $3.18 Million Position in Kenvue Inc. (NYSE:KVUE)

June 17, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

KVUE and JNJ Company Descriptions

Johnson & Johnson NYSE:JNJ

$151.82 +0.50 (+0.33%)

As of 10:27 AM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Kenvue NYSE:KVUE

$21.30 -0.07 (-0.35%)

As of 10:27 AM Eastern

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time